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Abstract 
Analysis linking directly genomics, neuroimaging phenotypes and clinical 
measurements is crucial for understanding psychiatric disorders, but remains rare. 
Here, we describe a multi-scale analysis using genome-wide SNPs, gene-expression, 
grey matter volume (GMV) and the Positive and Negative Syndrome Scale scores 
(PANSS) to explore the etiology of schizophrenia. With 72 drug-naive schizophrenic 
first episode patients (FEPs) and 73 matched heathy controls, we identified 108 genes, 
from schizophrenia risk genes, that correlated significantly with GMV, which are 
highly co-expressed in the brain during development. Among these 108 candidates, 19 
distinct genes were found associated with 16 brain regions referred to as hot clusters 
(HCs), primarily in the frontal cortex, sensory-motor regions and temporal and 
parietal regions. The patients were subtyped into three groups with distinguishable 
PANSS scores by the GMV of the identified HCs. Furthermore, we found that HCs 
with common GMV among patient groups are related to genes that mostly mapped to 
pathways relevant to neural signaling, which are associated with the risk for 
schizophrenia. Our results provide an integrated view of how genetic variants may 
affect brain structures that lead to distinct disease phenotypes. The method of 
multi-scale analysis that was described in this research, may help to advance the 
understanding of the etiology of schizophrenia.  
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Introduction 
Schizophrenia is one of the most common psychotic disorders worldwide, with a 
lifetime prevalence of 0.3 to 0.7 percent (van Os and Kapur, 2009). The age of onset 
of Schizophrenia is typically in late adolescence or early adulthood, with males more 
often affected than females(Gejman et al., 2010). The heritability of schizophrenia has 
been reported to range from 44% to 87% with a mean of 81% (Sullivan et al., 2003). 
Schizophrenia is increasingly recognized as a collection of syndromes as opposed to a 
single disease entity, and involves a number of cognitive and emotional impairments 
(A. Jablensky, 2006; Assen Jablensky, 2010).  
The advances in new generation sequencing approaches, neuroimaging 
technologies and a variety of clinical questionnaires have provided an unprecedented 
opportunity to understand psychiatric disorders like schizophrenia. For example, 
genome wide association studies (GWAS) provided unique ways to explore the 
potential genetic causes of schizophrenia. Thousands of loci on the genome have been 
identified to be associated with schizophrenia (Allen et al., 2008), e.g. ANK3, 
ZNF804A, CACNA1C, NRG1, TCF4 and MHC region, etc (O'Donovan et al., 2008; 
Ripke et al., 2013; Schwab and Wildenauer, 2013). Schizophrenia is believed to be a 
polygenetic disease, and Gilman et al. identified gene networks from different types 
of schizophrenia-associated genetic variations (Gilman et al., 2012). Schizophrenia 
associated genes harboring de novo mutations showed significant spatio-temporal 
co-expression patterns when mapped onto transcriptome profiles of normal human 
brain tissues (Gulsuner et al., 2013). 
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Neuroimaging studies based on magnetic resonance imaging (MRI) methodology 
have led to a better understanding of the neuroanatomical basis of schizophrenia. 
Structural brain alterations, in particular grey matter density or grey matter volume 
(GMV) in the whole brain or regions such as the hippocampus, parahippocampal 
gyrus, amygdala, thalamus, insular cortex, anterior cingulate, left middle frontal gyrus, 
and postcentral gyrus have been reported to be reduced in schizophrenic patients 
relative to healthy controls (Honea et al., 2005; Steen et al., 2006; Glahn et al., 2008; 
Gupta et al., 2015; van Erp et al., 2015). Twin, family or sibling-based studies have 
suggested that brain morphology characterized by neuroimaging quantitative 
measures is highly heritable (Sullivan et al., 2003; Thompson et al., 2010; Turner et 
al., 2012). The development of imaging genetics methods has leveraged the 
understanding of the possible genetic bases of brain structural differences and made it 
possible to map the genetic effects onto brain regions (Ge et al., 2013).  
The symptoms of schizophrenia are heterogeneous and are mainly categorized 
into two major types, the positive symptoms and the negative symptoms. The positive 
symptoms, which represented as an excess or distortion of normal functions such as 
hallucinations and delusions. The negative symptoms which refer to the loss or 
diminution of normal functions, for example, absence in grooming, language or 
communication. The psychotic severity is often assessed by different rating scales, 
such as the Positive and Negative Syndrome Scale (PANSS), Brief Psychiatric Rating 
Scale (BPRS), Scale for the Assessment of Positive Symptoms (SAPS) or Scale for 
the Assessment of Negative Symptoms (SANS) (Overall and Gorham, 1962; Kay et 
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al., 1987). Whitford TJ et al. (Whitford et al.) suggested that the symptom severity is 
associated with brain structural abnormality in schizophrenia. Nesvåg R et al. (Nesvåg 
et al., 2009) reported that the positive and negative symptoms in patients with 
schizophrenia can be related to variation in cortical and grey matter volumes. 
Despite the large number of investigations in genetics, structural and functional 
brain changes, and behavioral abnormalities of schizophrenia, there are currently few 
studies that identify simultaneously links through genetics, neuroimaging and 
behavior, where much correlations exhibit among these aspects. Existing approaches 
usually focus on one scale or across two scales, which lead to incomplete 
understanding of disease etiology. Therefore, a framework that harnesses multi-scale 
data, from genetics through endophenotypes, e.g. brain structure, to phenotypes such 
as symptom severity is crucial for understanding schizophrenia. 
In this study, we describe a multi-scale analysis that utilizing data from genomics, 
transcriptomics, neuroimaging, and clinical measurements to explore the etiology of 
schizophrenia. We first established a link between genes and brain structural (grey 
matter) changes by association study using schizophrenia risk genes reported in the 
SZGene database (Allen et al., 2008) and structural MRI imaging of the brain. Genes 
that showed significant association with grey matter volume (GMV) were selected as 
candidates and further validated by analyzing their spatio-temporal co-expression 
patterns in normal human brain during development. The collective brain regions 
which associated with candidate genes were referred to as hot clusters (HCs). The 
mean GMV of the identified HCs were used to subtype patients, and the patients of 
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different subtypes were found to have distinguishable PANSS scores. By this 
multi-scale analysis, we linked genetically associated brain structural alterations to the 
symptoms of schizophrenic patients. We hypothesize that the identified genes cause 
structural brain changes, which further lead to distinct behavioral expressions of 
schizophrenic patients. The integrated results across multi-scale data (i.e. genetic, 
neuroimaging, behavioral) are expected to provide a more complete understanding of 
the genetic and biological mechanisms underlying schizophrenia, and to shed light 
into how genetic variation and brain structural alterations are related to different 
symptom scores in patients with schizophrenia.  
 
 
Results 
Pre-processing of brain MRI data and selection of schizophrenia risk genes 
A total of 145 Han Chinese subjects took part in this study, which were recruited from 
the Mental Health Center of West China Hospital, Sichuan University in China. These 
subjects including 72 drug-naive schizophrenic first episode patients (FEPs) and 73 
heathy controls who were all matched with age, gender, and years of education (see 
Supplementary Table S1). The diagnosis of schizophrenia and duration of illness were 
determined by the consensus of the attending psychiatrist and a trained interviewer 
using the Structured Clinical Interview for DSM-IV (SCID-P), and the diagnoses of 
all patients were confirmed after at least one year of follow up. Healthy controls were 
recruited from the local area through poster advertisement and screened using 
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SCID-NP to confirm the lifetime absence of psychiatric and neurological illness. In 
addition, the control subjects were interviewed to ensure that there was no history of 
psychiatric illness in first-degree relatives. Brain structural magnetic resonance 
imaging (MRI) was obtained from each subject through identical scanner and imaging 
protocols. Genetic data for every participant were also collected. The study protocol 
was approved by the ethical committee of the West China Hospital of Sichuan 
University.  
High-resolution T1-weighted images were acquired from samples on admission 
using a 3-Tesla MRI system (EXCITE, General Electric, WI, USA) and an 
eight-channel phase array head coil with a volumetric 3D Spoiled Gradient Recall 
(SPGR) sequence. The voxel-based morphometry (VBM) preprocessing of 
T1-weighted structural data was carried out using DARTEL Tools from the Statistical 
Parametric Mapping package (SPM8, http://www.fil.ion.ucl.ac.uk/spm) under 
MATLAB Release 2014a (The MathWorks, Natick, 2014). Each retained image had a 
total of 433,584 voxels (with size: 1.5mm
3
) for further statistical analysis. The 
automated anatomical labeling (AAL) (Tzourio-Mazoyer et al., 2002) atlas, which 
partitioned the brain into 90 regions of interest (ROIs; 45 in each hemisphere), was 
used to identify the brain regions (See Supplementary Text S1 for more details). 
The Genetic data were extracted by performing the HumanOmniZhongHua-8 
Bead Chip (Illumina, San Diego, CA). Participants with a low genotyping rate 
(<97%), markers with >5% missing data and markers with minor allele frequency 
(MAF) ≤0.05 (calculated based on both case and control samples) or markers that 
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failed to pass the Hardy-Weinberg equilibrium tests (p ≤ 10-6) were excluded from 
further analysis.  
The SZGene database identified 994 schizophrenia risk genes reported from 
various genome-wide association studies, including both protein-coding and 
non-coding genes. Only protein coding genes reported by the SZGene database 
(http://www.szgene.org/) which also appeared in the expression data list of BrainSpan 
database (http://www.brainspan.org/) were considered in this study. After mapping all 
SZGene genes to the selected genes from the BrainSpan dataset (see below), and after 
quality control, 718 schizophrenia risk genes with 20,982 SNPs were retained for 
further analysis. Note that the SNPs are mapped to the genes according to the 
annotation on Ensembl database. The SNPs within the range of a gene are annotated 
by the gene symbol. We did not distinguish between the exon or intron types of the 
SNPs in this study. 
Association between risk genes and grey matter variation 
We assessed the associations of the 718 protein coding genes that convey risk for 
schizophrenia with voxel-wise brain structural variation (e.g. grey matter volume). Of 
all 718 genes, 108 genes remained significant and were selected as candidates, 
including 246 SNPs in association with 6103 voxels. The top 20 significant SNPs 
ranked by minimum p-values are given in Table S3 and the mapped location within 
the brain region according to the top 4 significant SNPs are displayed in Figure S1.  
The 108 candidate genes are highly co-expressed in a spatio- and 
temporal-specific manner 
D
ow
nloaded from
 https://academ
ic.oup.com
/jm
cb/advance-article-abstract/doi/10.1093/jm
cb/m
jy071/5227766 by U
niversity of W
arw
ick user on 22 January 2019
9 
 
We constructed 12 spatio-temporal gene co-expression networks from 718 risk genes 
accounting for 4 anatomic brain regions across 3 developmental stages 
(Supplementary Table S2). The empirical distributions of interconnectedness of 108 
randomly sampled genes (out of the risk genes) in these 12 networks are shown in 
Figure 1. We found that the distribution of interconnectedness of the candidate genes 
change with different developmental stages. During the early infancy to late 
childhood stage and the adolescence to adulthood stage the candidate genes showed 
significantly stronger interconnectedness in networks corresponding to the frontal 
cortex (FC) region, the sensory-motor regions (SM), and the temporal and parietal 
regions (TP) of brain (p-value < 0.01). The interconnectedness of candidate genes was 
also stronger in the frontal cortex (FC) region during the fetal period and in the 
subcortical regions during the adolescence to adulthood stage (p-value < 0.1) (Fig 1, 
Table S4).  
Stability tests showed that the significances of interconnectedness under different 
thresholds and weighting strategies were robust (Table S4). The interconnectedness of 
candidate genes also showed no significant result in networks constructed from 718 
genes by merging all spatial and temporal samples from BrainSpan (the last row of 
Table S4 shows the results of merged BrainSpan samples). No significant results were 
obtained when candidate genes were tested using protein-protein interaction from 
GeneMANIA (Mostafavi et al., 2008) (p-value=0.318).  
Nineteen candidate genes are associated with 16 grey matter hot-clusters in brain 
Connected brain region that were collectively associated with candidate genes were 
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identified as hot clusters (HCs) (for details of these genes and HCs see Table 1 and 
Table S5). We observed that among the 108 candidate genes there are 19 different 
genes, which we refer as to HC genes, associated with 16 hot clusters (HCs), where 
the HC1~HC16 were named according to the decreased rank of the maximum voxel 
weight of each HC. Figure 2 shows the locations of the HCs in 3D view and the 
coronal view of each HC is shown in Figure S2 with intensity representing the 
corrected weight of each voxel. The cluster with the maximum single voxel weight is 
HC1, which also formed the largest cluster with a total of 945 voxels. It is associated 
with genes CACNA1A or ERBB4 and located in the right insula (INS.R) region. HC2 
is in association with PPP1R1B. It incorporates 438 voxels that lie in the left 
precuneus (PCUN.L). HC3 lies in the left middle temporal pole (TPOmid.L) with 118 
voxels and is related to ATP2B2. HC4 is in association with genes NRG3 and PPP3C. 
It located in the right middle temporal pole region (TPOmid.R). HC5, which is 
associated with PPP3CA and RELN, locates across the right precentral region 
(PreCG.R). Table 1 and Table S5 show more information on the identified HCs. 
The HC genes are found to be mapped to neuro signaling and related pathways 
(Fig S3). Genes CACNA1A, ERBB4, ATP2B2, PPP3CA and PRKCA that affect HC1, 
HC3, H4 and H13 can be related to the calcium signaling pathway (Fig S3A). 
CACNA1A encodes P/Q-type calcium channels, which are the targets of Dopamine D2 
receptors for antipsychotic drugs (Galizzi et al., 1986; Nimmrich and Gross, 2012). 
The cAMP pathway, where the PPP1R1B gene of HC2 is located, is the 
interconnecting node for the Dopamine D2 receptor cascade of the P/Q-type calcium 
D
ow
nloaded from
 https://academ
ic.oup.com
/jm
cb/advance-article-abstract/doi/10.1093/jm
cb/m
jy071/5227766 by U
niversity of W
arw
ick user on 22 January 2019
11 
 
channels (Greengard et al., 1999). Gene INPP4B (HC7) was found mapped to the 
phosphatidylinositol signaling pathway, which locates downstream to the calcium 
signaling pathway (Fig S3A). Genes ERBB4, NRG3 and PRKCA are mapped to the 
ERBB signaling pathway which is located upstream of the calcium signaling pathway 
(Fig S3B). Recent studies provided strong evidence that the calcium and ERBB 
signaling pathways are associated with schizophrenia (Cross-Disorder Group of the 
Psychiatric Genomics, 2013; Harrison, 2015). Mutations of the ERBB4 gene 
differentially affected the treatment response to paliperidone in individuals with 
schizophrenia, implicating the neuregulin 1 (NRG1)-ErbB4 pathway for modulating 
the antipsychotic response (Wang et al., 2015). ERBB4 is activated directly by gene 
NRG3 (related to HC4 and HC13). The ERBB4 gene activates the downstream 
PI3K-Akt signaling pathway which gene RELN (HC5) and FGF1 (HC14) mapped to 
(Fig S3B) (Law et al., 2012). RELN is a key gene for neuronal migration during brain 
development. Mutation of the RELN gene in the mouse results in motor problems 
(Sanes et al., 2012). A lack of RELN causes a form of lissencephaly (Hong et al., 
2000). Further, the Neuregulin1-ErbB4-PI3K signaling has been shown to be a 
schizophrenia risk pathway, with potential therapeutic relevance (Law et al., 2012). 
Genes CACNA1A, PPP1R1B, PPP3CA and PRKCA are related to the Dopaminergic 
Synapse pathway (Fig S3C). Genes CACNA1A, PPP3CA and PRKCA also function in 
the Glutamatergic Synapse pathway (Fig S3D). Dopaminergic and glutamatergic 
systems are closely related in the brain: dopaminergic activity can inhibit 
glutamatergic function and can result in a hypoglutamatergic state in schizophrenia 
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(Kötter, 1994; Bradford, 2009). 
Patients subtyped according to GMV of HCs show differences in 
positive/negative symptom scale 
The symptoms of schizophrenia patients can be heterogeneous with two main types, 
namely, the positive symptoms and the negative symptoms. These symptoms are 
related to the variation in cortical and grey matter volumes of schizophrenia patients 
(Nesvåg et al., 2009). We have 67 schizophrenia patients with PANSS scores. We thus 
hope to subtype the patients according to their gray-matter variation of HCs and 
further characterize their symptoms.  
We have 67 schizophrenia patients with PANSS scores and they were subtyped by 
K-means method according to their gray matter volume (GMV) of HCs. The optimum 
number of groups was set to 3 according to the index of in-groups proportion (Kapp 
and Tibshirani, 2007) (IGP) (Fig 3A). Figure 3B shows the GMV correlation map of 
the 3 groups of clustered patients. The sizes of the groups are 17, 28 and 22, 
respectively, with no significant difference in gender and age composition (data not 
show). As shown in Figure S4A, patients in group 1 has higher mean scores on 5 of 
the 7 items in the positive PANSS symptoms, while group 2 patients showed more 
items with of higher mean negative PANSS symptom scores (5/7). All three group 
patients had their mean scores intermixed with each other on items in the general 
PANSS psychopathology scale (Fig S4A).  
We tested the differences in the subscales of PANSS between groups by random 
permutation of patients‘ group labels. The three groups showed similar means in the 
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total score (TT) and general psychopathology score (G) (Fig S4B, C). Group 1 had a 
relatively higher positive score (P) and lower negative score (N), and thus, a 
significantly larger composite score, which defined by subtracting the negative from 
the positive score and we designated as PN for short (mean PN = 10.3, p < 0.05; PN 
are 3.9 and 6.3 in groups 2 and 3, Fig 4A). In contrast, an opposite trend was observed 
for group 2 (Fig 4A). When compared pairwise, the PN differences between groups 1 
and 2, and between groups 1 and 3 were also significant (p-values < 0.05 and < 0.1 
respectively, Fig 4B). 
Figure 4C shows the mean GMVs for each HC within patient groups. We 
conducted Wilcoxon rank sum tests to evaluate the mean GMV difference of HC 
between patients in one group versus the remaining. For each group the p-values were 
corrected by Bonferroni method over the 16 HCs (p-values < 0.05/16). The results 
show that on HC6, HC9 and HC15, patients of group 1 had significantly different 
GMV compared to those of the remaining patients (Table S6). Group 2 patients had 
mean GMV varied from the others on HC14, and group 3 patients had significantly 
different GMV on HC9 and HC14. 
 
Discussion 
In this investigation, we describe a multi-scale analysis across data of multiple scales 
to identify clusters of attributes related to schizophrenia. We identified 108 candidate 
genes from 718 schizophrenia risk genes that exhibit association with grey matter 
volume (GMV) of the brain. These candidate genes are highly co-expressed in frontal 
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cortex (FC) and temporal and parietal regions (TP) during the early infancy to 
childhood period, and in sensory-motor regions (SM) through the early infancy to 
adulthood period. Among these 108 candidate genes, 19 distinct genes were further 
identified to be associated with the GMV of 16 hot clusters in the brain which were 
also mainly located in FC, TP and SM regions. Recent studies have suggested that 
subtypes of schizophrenic symptoms may be linked to specific patterns of structural 
brain alterations (Koutsouleris et al., 2008; Nenadic et al., 2010; Zhang et al., 2015). 
Our results show that the identified HCs may serve as multidimensional traits which 
are able to characterize important features of the structural variations of schizophrenia 
patients that manifest in distinguishable symptoms. The patients are subtyped into 
three groups by using GMV of 16 HCs, with patients in group 1 showing more severe 
positive symptoms and patients of group 2 showing higher negative symptoms scores. 
In this study, the HCs were identified by genes with variations highly associated 
to the gray matter variation of these regions. It does not mean that these genes are 
restricted to function in the HCs. Since schizophrenia is a development disorder, the 
HCs can be regarded as the initial points of schizophrenia that have gray matter 
abnormality. With the development of schizophrenia, these initial points will spread 
out (like a diffusion processes). All of these do not conflict with the view that gene 
expression in the brain is widespread. In fact, as the results in our spatio-temporal 
expression analysis, the candidate genes are highly co-expressed in a core region of 
human (frontal cortex) at first, and spread to co-express in most brain regions as 
developmental progresses. Here we found that schizophrenia has multiple initial 
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points (HCs), and different HCs are shown to be associated with different subtypes of 
schizophrenia. 
More interestingly, the genes related to HCs that show little mean GMV 
difference between the three patient groups, such as HC1, HC5, HC7, HC10, HC12, 
HC13 and HC16, are mainly mapped to KEGG pathways relevant to neural signaling 
(Fig S3). These pathways are known to be most basic in neurodevelopment (Karam et 
al., 2010; Berwick and Harvey, 2014; J. Wu, 2017). We hypothesize that these HCs 
carry common GMV variation that contribute in all schizophrenic patients.  
The differed symptoms, on the other hand, might be contributed by HC6, HC9, 
HC14 and HC15, which show much variance among patient groups. In detail, group 1 
patients had significantly reduced mean GMV as compared to patients of other groups 
in HC6. The HC6 located in the left supramarginal region, which is related to 
language perception and processing. In HC15, which located in the right median 
cingulate and paracingulate gyri, patients of group 1 had a larger mean GMV. This 
region is implicated in error detection, attention or motivation-related functions and is 
reported to be associated with schizophrenia (Posner and DiGirolamo, 1998). Group 2 
patients had a greater mean GMV on HC14, which located in the left angular gyrus 
and associated with language. The three groups have quite distinct mean GMVs on 
HC9, where group 1 patients have the lowest mean GMV, and group 3 patients has a 
significantly larger mean, with the mean GMV of patients of group 2 in between. HC9 
located across the left cuneus, superior occipital gyrus, superior parietal gyrus and 
precuneus regions. These regions are involved in visual processing, spatial 
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orientation, episodic memory, visuospatial processing, reflections upon the self, and 
aspects of consciousness. In particular, the precuneus, where HC2 and HC13 were 
also located, along with adjacent areas within the posteromedial parietal cortex, has 
attracted increasing attention, as it is among the most active cortical regions according 
to the ―default mode‖ of brain function during the conscious resting state, whereas it 
selectively deactivates in a number of pathophysiological conditions and 
neuropsychiatric disorders, including schizophrenia, characterized by impaired 
information processing (Cavanna, 2007). 
Finally, there are several remarks we would like to address. First, our goal was to 
search for potential collective effects of multiple genes rather than looking for new 
genetic locations correlated with brain structural variation. The SZGene database 
which we used to extract schizophrenia risk genes, although stopped updating, 
includes the largest collection of schizophrenia related genes to our knowledge. 
However, our method can be easily applied to an extended list of genes. Second, the 
transcriptional profiles obtained from BrainSpan are non-psychiatric postmortem 
donors. This study is therefore limited to examining the co-expression pattern of 
candidate genes within the group of putatively normal persons. We believe that, with 
the accumulation of transcriptome samples on psychiatric patients in the future, 
examining the possible cis- and trans- effects on variants, and in turn the gene 
expression characteristics in specific HCs will establish strengthen the understanding 
of links between the genetics and the symptoms of schizophrenia (Bray et al., 2008; 
Jiang, 2015; M. Wu et al., 2017). Third, studies of schizophrenia are more 
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increasingly interested in using functional MRI data (Gong and Lin, 2018). Our 
findings revealed that the collective effects of candidate genes on HCs of SCZ 
patients may result in different symptoms as characterized by the PANSS score. 
However, how these HCs are functionally connected or how they are related to other 
regions calls for further investigation. Last, the symptoms of patients, which subtyped 
into 3 groups according to the HCs, are distinguishable by the scores on the positive 
and negative items of PANSS in this study. It is expected that with a larger size of 
samples together with multi-scale data, a more refined classification of patients may 
be possible. 
 
Materials and Methods  
Brain developmental gene expression data 
The BrainSpan database contains the largest transcriptome profiles of human brain 
development with up to sixteen cortical and subcortical structures across the full 
course from post conception weeks (PCWs) to adulthood. We used this data to 
evaluate the spatial-temporal co-expression of selected candidate genes. The brain 
developmental gene expression data from BrainSpan database. After filtering out 
non-coding genes, and genes with low expression level, a total of 15,272 genes were 
retained as background for further co-expression analysis (see Supplementary Text 
S2). 
Identification of candidate genes using the linear regression model 
A linear regression model (Gong et al., 2014) was used to detect the association 
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between single gene/SNP and the grey matter volume (GMV) of voxels in brain, with 
age, gender and education as covariates (Supplementary Text S3). A risk gene was 
selected as a candidate if at least one SNP of the gene had a minimum p-value<1× 
10
-6
 (see the Supplementary Text S4 on the discussion of false discovery rate controls). 
The analysis was performed using MATLAB Release 2014a (The MathWorks, Natick, 
2014).  
Construction of spatio-temporal co-expression gene networks 
The BrainSpan dataset was divided into 12 sub-sets according to 4 anatomical regions 
of the brain and 3 predefined developmental stages (Table S2). In particular, the brain 
was partitioned into non-overlapping regions: frontal cortex (FC), temporal and 
parietal regions (TP), sensory-motor regions (SM), and subcortical regions (SC); and 
samples were categorized into developmental stages according to their ages: fetal (8–
37 post-conception weeks), early infancy to late childhood (4 months to 8 years), and 
adolescence to adulthood (13–40 years) (Gulsuner et al., 2013) (see Supplementary 
Table S2 for more details). For each sub-set, the absolute Pearson correlation 
coefficients (denoted as |PCC|) of expression of each pair of the schizophrenia risk 
genes were calculated. As strong correlation of expression between a pair of genes 
may potentially indicate high relevance to function, we applied a common threshold 
of |PCC| > 0.8, and set values below the threshold to 0. Twelve spatio-temporal 
specific weighted gene co-expression networks, each with risk genes as nodes and 
edges assigned with threshold |PCC|s, were thus constructed. The co-expression 
strength of a set of genes was characterized by interconnectedness, which was defined 
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as the sum of the edges‘ weights among the set of genes.  
We applied a resampling procedure to test if the candidate genes are highly 
interconnected. The stabilities of the results were also evaluated by comparing 
different |PCC| thresholds (|PCC|=0.8, unweighted networks and merged networks 
(Supplementary Text S5). The analysis was performed using R environment 
(https://www.R-project.org/). 
Construction of grey matter hot clusters based on collective genetic effects  
Since many common genetic variants of small effect may contribute to the variation 
of GMV, we clustered the voxels with GMV closely associated with a number of 
candidate gene/SNPs. All voxels were first weighted by the number of SNPs which 
were significantly associated with their GMV. The weights of the voxels were further 
corrected taking into consideration the linkage disequilibrium (LD) among SNPs that 
are physically located on the same chromosome (Supplementary Text S6) and 
spatially smoothed by an isotropic Gaussian kernel (full-width at half-maximum=8 
mm). Voxels with weight exceeding a pre-defined threshold of 0.2304 
(Supplementary Text S7) were merged to form clusters based on a connectivity rule, 
that is, voxels sharing at least one edge or side. We named these identified clusters as 
hot clusters (HCs). 
Subtyping schizophrenic patients by hot clusters  
We applied the K-means clustering approach using grey matter volume (GMV) of the 
hot-clusters to divide the 67 patients that PANSS scores (Kay et al., 1987) into 
different groups. For each patient the GMV of HCs were extracted and used as 
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multi-dimensional features. The metric used for clustering was unity minus the 
correlation of the corresponding multi-dimensional features. In-group 
proportion(Kapp and Tibshirani, 2007)（IGP）, which quantifies the proportion of 
samples in a group whose nearest neighbors are also in the same group, was adopted 
to measure the quality of the clustering results.  
The optimum number of groups (clusters) was determined according to the 
average IGP of all groups (the numbers of groups tested were from 2 to 10). For each 
number of groups chosen, 1000 replicate runs were conducted with locations of the 
centroid for each group initiated randomly. The sum of the pointwise distances to their 
centroid within groups was calculated for each replicate, and the minimum sum was 
chosen as the final outcome.  
The total PANSS score (TT), and four subscales, namely, the positive scale score 
(P), the negative scale score (N), the general psychopathology scale score (G), and the 
composite scale score (defined by subtracting the negative from the positive score, i.e., 
PN), were calculated for each patient. The mean scores were compared across groups 
for each subscale by random permutation of the group label of patients for 10000 
times. The p-values were obtained as the percentile where the true value lies in the 
empirical distribution from 10000 permutations. All analyses were performed using R 
environment (https://www.R-project.org/). 
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Figure 1. The p-values of the interconnectedness of the 108 candidate genes in the 12 
spatial-temporal brain developmental gene networks 
The subplots of each row correspond to 4 anatomical regions—frontal cortex (FC; 
first row), subcortical regions (SC, second row), sensory-motor regions (SM; third 
row); and temporal and parietal regions (TP; fourth rows). The subplots of each 
column showed the 3 brain developmental stages— fetal (period 1: 8–37 
post-conception weeks; front column), early infancy to late childhood (period 1: 4 
months to 8 years; middle column); and adolescence to adulthood (period 3: 13–40 
years; last column). Each subplot presents the empirical distribution of 
* * * * * 
* * * * 
* * * * 
* 
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interconnectedness of 108 genes which drawn randomly from 718 schizophrenia risk 
genes. The empirical distributions were generated by resampling 10,000 times at each 
spatial and temporal period. The red vertical dashed line in each subplot shows the 
interconnectedness of the 108 candidate genes. The p-values of the interconnectedness 
of the candidate genes were calculated as the fraction of the interconnectedness of 
10,000 sets larger than the observed interconnectedness (corresponding to column 
―p-0.8w‖ of Table S4). The spatio-temproal networks with 108 candidate genes 
presented significant at p-value < 0.01 were annotated with *** and at p-value < 0.1 
were annotated with *. 
 
Figure 2. 3D image of the 16 hot-clusters identified  
The hot-clusters were denoted as ―HC1‖, ―HC2‖,…, ―HC16‖ according to Table 1. 
Each hot-cluster is represented with a unique color. The coronal views of each cluster 
are shown in Figure S2, with intensity representing the corrected weight of each voxel. 
The exact location and the related genes of each hot-cluster are provided in Table 1 
and Table S5. 
 
Figure 3. Identification of subtype patients by GMV of HCs 
A. The number of classes against mean in-group proportion (IGP). The optimum 
number of classes (groups) is identified by maximizing IGP. 
B. Heat map of the three groups identified according to grey matter densities (GMVs) 
of the16 HCs. The patients were sorted by groups. The colors represent the 
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correlation coefficient (as displayed in the color bar) of GMVs over 16 HCs of 
two corresponding patients.  
 
Figure 4. Positive and negative scores in different subtyped patients 
A. Boxplots of mean positive (P), negative (N) and composite (PN) scale scores over 
10000 permutations. The red ‗*‘ represent the mean score of the original 
un-permuted groups.  
B. The empirical distribution of the Group-wise difference over 10000 permutations. 
The mean difference of the composite scale (PN) scores between groups 1 and 2 
(MeanPN12), groups 1 and 3 (MeanPN13), and groups 2 and 3 (MeanPN23) over 
10000 permutations are shown in histograms. The x-axis represents the difference 
of group mean scores of the pair of permutated groups. The quantile of the p-value 
is represented by red lines. The x-axis represents the difference of the mean 
composite scale scores of a pair of permuted groups. The quantile of p-value is 
represented by red lines. 
C. The mean group GMV of each HCs, with Group 1 shown in red, Group 2 in green 
and Group 3 in blue. The red ‗*‘ indicate significant differences in GMV of the 
corresponding HC among groups (Table S6). 
 
Table 1 Hot clusters and associated genes 
 Associated Genes AAL region Brain Region
* 
Cluster Size 
HC1 
CACNA1A 
ERBB4 
Insula_R SM 945 
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HC2 PPP1R1B Precuneus_L TP 438 
HC3 ATP2B2 Temporal_Pole_Sup_L TP 118 
HC4 
PPP3CA 
NRG3 
Temporal_Pole_Mid_R TP 134 
HC5 
ZBTB20 
RELN 
Precentral_R SM 157 
HC6 OPCML SupraMarginal_R TP 74 
HC7 INPP4B Frontal_Mid_L FC 63 
HC8 ZNF365 Temporal_Mid_R TP 44 
HC9 ANK3 Precuneus_L TP 47 
HC10 ZBTB20 Parietal_Inf_L TP 31 
HC11 PSAP Lingual_L OC 33 
HC12 
BMP6 
EIF2B5 
Supp_Motor_Area_R SM 20 
HC13 
NRG3 
PRKCA 
Precuneus_R TP 16 
HC14 FGF1 Angular_L TP 11 
HC15 SLIT3 Cingulate_Mid_R FC 8 
HC16 GFRA2 Hippocampus_R SC 11 
The hot clusters and HC genes. The number of voxels contained in the HCs are listed 
in the last column. More details can be found in Table S5. 
*frontal cortex (FC), temporal and parietal regions (TP), sensory-motor regions (SM), 
subcortical regions (SC), occipital regions (OC) 
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